- Home
- Equipment
- usa washington
- cell and gene therapy
Refine by
Cell And Gene Therapy Equipment Supplied In Usa Washington
11 equipment items found
Manufactured by:AGC Biologics based inBothell, WASHINGTON (USA)
AGC Biologics develops and manufactures diverse cell therapies including CD34+ hematopoietic stem cells, autologous and allogenic T-cells, and NK cells. Our cell therapy capabilities cover numerous technologies, ranging from closed to open systems at different scales, ...
Manufactured by:AGC Biologics based inBothell, WASHINGTON (USA)
AGC Biologics develops and manufactures Lenti and Retro viral vectors. Our ready-to-use platform capabilities are built on cell factories (up to 48L) and bioreactors (up to 200L) using adherent processes, designed entirely in-house. Our quality systems, GMP manufacturing scale and regulatory qualification allow us to meet both clinical and commercial demand. ...
Manufactured by:Universal Cells Inc. based inSeattle, WASHINGTON (USA)
Pluripotent stem cells (PSCs) such as embryonic stem cells (ESCs) and induced PSCs (iPSCs) are undifferentiated stem cells that can differentiate into any cell type found in the body. Scientists around the world are using PSCs to produce more mature cell types with diverse therapeutic functions. These new cell therapies have the potential to change the lives of patients suffering from diseases of ...
Manufactured by:Adaptive Biotechnologies based inSeattle, WASHINGTON (USA)
We are currently leveraging our TCR discovery capabilities to enable commercialization of novel therapies by collaborators. In the future, we may explore expanding our end-to-end capabilities for the development of cellular therapies and vaccines. TruTCR is summarized in the figure ...
Manufactured by:Aptevo Therapeutics based inSeattle, WASHINGTON (USA)
APVO603 is a dual agonist bispecific antibody employing a novel mechanism of action to simultaneously target 4-1BB (CD137) and OX40 (CD134), both members of the TNF-receptor family. Dual targeting of 4-1BB and OX40 provides synergistic co-stimulation of T cells with the potential to amplify the cytotoxic function of activated T cells and NK cells, potentially leading to more robust anti-tumor ...
Manufactured by:Universal Cells Inc. based inSeattle, WASHINGTON (USA)
Realizing the potential of pluripotent stem cells requires that the therapeutic cells derived from PSCs be accepted by patients. PSC-derived cells that have not been engineered to avoid allogeneic rejection will be eliminated soon after transplantation unless they are HLA-matched to their recipients, delivered to immune privileged sites, or administered along with potentially dangerous ...
Manufactured by:ELITechGroup based inPuteaux, FRANCE
Aspergillosis is the most common cause of fungal infection among stem cell and solid organ transplant recipients, resulting in high mortality if untreated. Patients with weakened immune system and lung diseases are at higher risk of developing severe outcomes. Early detection and quantification of Aspergillus with molecular methods is crucial to isolate infected patients and provide an ...
by:AVM Biotechnology based inSeattle, WASHINGTON (USA)
Most people who get ARDS are already at the hospital for trauma or illness. Lung injuries can occur from trauma, an overwhelming immune response due to an infection, allergic reaction or a cell/gene therapy product or trauma, accidents, ...
Manufactured by:ELITechGroup based inPuteaux, FRANCE
Epstein-Barr Virus (EBV) is a widespread herpesvirus, generally asymptomatic or sometimes responsible for mild infection like mononucleosis. After solid organ or hematopoietic stem cell transplant, EBV reactivation is a common cause of malignant transformation, called Post-Transplant Lymphoproliferative Disorder “PTLD”. EBV viral load monitoring is important to diagnose, and monitor ...
Manufactured by:Aptevo Therapeutics based inSeattle, WASHINGTON (USA)
APVO436 is an optimized ADAPTIR bispecific antibody candidate designed to redirect T-cell cytotoxicity through the dual targeting of CD3, a T-cell co-receptor that promotes cytotoxicity, and CD123, a cell surface receptor highly expressed in several hematological malignancies, including acute myeloid leukemia, acute lymphoblastic leukemia, hairy cell leukemia, myelodysplastic syndrome, and ...
Manufactured by:AST, Inc. based inTacoma, WASHINGTON (USA)
AST's Benchtop Container Filling System is a semi-automatic machine designed for small batch processing of sterile injectable products, focusing on filling pre-filled syringes, cartridges, vials, and bottles. Embracing cGMP standards, its aseptic design is compatible with environments such as cleanrooms and aseptic isolators. It features an integrated peristaltic pump that ensures precise ...